Raspberry v. Secretary of Department of Health

32 Fed. Cl. 777, 1995 U.S. Claims LEXIS 38, 1995 WL 75575
CourtUnited States Court of Federal Claims
DecidedFebruary 7, 1995
DocketNo. 91-1567V
StatusPublished
Cited by11 cases

This text of 32 Fed. Cl. 777 (Raspberry v. Secretary of Department of Health) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Raspberry v. Secretary of Department of Health, 32 Fed. Cl. 777, 1995 U.S. Claims LEXIS 38, 1995 WL 75575 (uscfc 1995).

Opinion

OPINION

ANDEWELT, Judge.

I.

In this action, petitioner, Donnella Raspberry, seeks compensation under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-l to -34 (the Vaccine Act), for the death of her daughter, Shanelle Eas-tling. Petitioner alleges that Shanelle’s death was caused by a DPT (diphtheria, pertussis, and tetanus) vaccination administered on August 20, 1990. On February 3, 1994, the special master issued a decision denying petitioner compensation. Pursuant to 42 U.S.C. 300aa-12(e)(l), petitioner filed a motion in this court for review of the special master’s decision, but that motion did not reach the clerk of this court until one day beyond the 30-day statutory time period. In a June 2, 1994, order, this court dismissed petitioner’s motion for review as untimely. This action is presently before the court on petitioner’s motion for reconsideration.

In support of her motion for reconsideration, petitioner submits an affidavit and receipts which demonstrate that on Saturday, March 5, 1994, two days (one business day) before the expiration of the statutory time period, petitioner sent her motion for review, correctly addressed, to the clerk of this court via Airborne Express, an established private carrier, which guaranteed overnight delivery. The carrier failed, however* to deliver petitioner’s motion to the clerk of this court, as guaranteed, on Monday, March 7, 1994, and instead delivered it one day later, on March 8. Petitioner asks this court to toll the statute of limitations and allow petitioner to file her motion for review one day beyond the 30-day statutory time period.

II.

The Vaccine Act establishes procedures, including time limits for filing petitions and motions for review, that petitioners must follow in order to secure compensation thereunder. As to motions for review, the Vaccine Act provides, in pertinent part:

(1) Upon issuance of the special master’s decision, the parties shall have 30 days to file with the clerk of the United States Court of Federal Claims a motion to have the court review the decision____

(2) Upon the filing of a motion under paragraph (1) ..., the United States Court of Federal Claims shall have jurisdiction to undertake a review of the record of the proceedings____

42 U.S.C. § 300aa-12(e).1

The 30-day period for the filing of motions for review is jurisdictional, and hence, if a [779]*779petitioner does not satisfy the requirements of Section 12(e)(1), this court lacks jurisdiction to hear the petitioner’s motion for review. Widdoss v. Secretary, HHS, 989 F.2d 1170, 1177 (Fed.Cir.), cert. denied, — U.S. -, 114 S.Ct. 381, 126 L.Ed.2d 331 (1993). But to say that a petitioner must satisfy the jurisdictional prerequisites of Section 12(e)(1) is not to say that this court necessarily lacks jurisdiction to consider a motion for review that is filed one day late. In Irwin v. Dep’t of Veterans Affairs, 498 U.S. 89, 95-96, 111 S.Ct. 453, 457, 112 L.Ed.2d 435 (1990), the Supreme Court concluded that there is a presumption that equitable tolling is available in suits against the federal government.(“[T]he same rebuttable presumption of equitable tolling applicable to suits against private defendants should also apply to suits against the United States.”) The Court reasoned that a presumption in favor of the availability of equitable tolling is “likely to be a realistic assessment of legislative intent as well as a practically useful principle of interpretation.” Id. at 95, 111 S.Ct. at 457.

Consistent with this focus on legislative intent, courts have concluded that a presumption favoring equitable tolling is rebutted when the language of a particular statute indicates that Congress intended the limitation period therein to be absolute and not subject to tolling. For example, in Lampf v. Gilbertson, 501 U.S. 350, 111 S.Ct. 2773, 115 L.Ed.2d 321 (1991), the Supreme Court held that courts cannot toll the statute of limitations applicable to the commencement of suits under the Securities Exchange Act of 1934. Section 9(e) of that act provides that a plaintiff must commence litigation “within one year after the discovery of the facts constituting the violátion and within three years after such violation.” 15 U.S.C. § 78i(e). The Court reasoned that “[t]he 1-year period, by its terms, begins after discovery of the facts constituting the violation, making tolling unnecessary. The 3-year limit is a period of repose inconsistent with tolling.” Id. at 363, 111 S.Ct. at 2782. Under such circumstances, the Court concluded that equitable tolling is “fundamentally inconsistent” with the structure of the statute of limitations provided in the Securities Exchange Act of 1934. Id.

Likewise, in Smith v. Secretary, HHS, 26 Cl.Ct. 116, 119 (1992), the Court of Federal Claims held that tolling the 28-month statute of limitations for commencing suits under the Vaccine Act would be inconsistent with congressional intent. The Smith court affirmed the special master’s conclusion that when Congress extended the statute of limitations from 24 to 28 months, Congress intended to establish an outer limit on the amount of time allowed for initiating a claim under the Vaccine Act. Id. at 119 & n. 4.

Pursuant to Irwin, Lampf, and Smith, this court must first determine whether Congress has expressed an intent that the doctrine of equitable tolling should not apply to the 30-day time limit set forth in Section 12(e)(1) of the Vaccine Act. If the court concludes that equitable tolling is available, the court must then determine whether petitioner has presented sufficient evidence to warrant the tolling of the 30-day statutory period for one day.

III.

A.

Unlike the findings in Lampf and Smith, this court cannot discern from Section 12(e)(1) any legislative intent to preclude equitable tolling. The first obvious difference between the statute of limitations in Section 12(e)(1) and those in Lampf and Smith is the length of the limitation periods. Section 12(e)(1) allows only 30 days for the filing of a motion for review, a significantly shorter amount of time than the one- and three-year periods in Lampf and the 28-month period in Smith. In Lampf, 501 U.S. at 363, 111 S.Ct. at 2782, the Supreme Court described the comparatively lengthy statutory periods as permitting “repose” and “making tolling unnecessary.” This court cannot arrive at a similar conclusion with respect to the far shorter 30-day period in Section 12(e)(1).

[780]*780Indeed, Section 12(e)(1) requires a petitioner to make critical decisions and perform a series of time-consuming tasks within the 30-day period. A petitioner first must study the special master’s decision and then decide whether to seek review.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
32 Fed. Cl. 777, 1995 U.S. Claims LEXIS 38, 1995 WL 75575, Counsel Stack Legal Research, https://law.counselstack.com/opinion/raspberry-v-secretary-of-department-of-health-uscfc-1995.